Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2014 / Cilt: 40 - Sayı: 1

The feasibility of radical cystectomy in elderly patients

Pages
9–14
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Five-year overall survival rates were 43.9% for Group 1 and 45.9% for Group 2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this study, we aimed to investigate the relationship between age and tumor characteristics and to evaluate oncologic results after radical cystectomy in bladder cancer with respect to age.
📊
Key Findings & Data:Material and methods: We reviewed 460 patients retrospectively who underwent radical cystectomy.
💡
Conclusion & Impact:Five-year overall survival rates were 43.9% for Group 1 and 45.9% for Group 2.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: In this study, we aimed to investigate the relationship between age and tumor characteristics and to evaluate oncologic results after radical cystectomy in bladder cancer with respect to age. Material and methods: We reviewed 460 patients retrospectively who underwent radical cystectomy. Pa- tients were divided into two groups according to age: &#8805;70 (Group 1), and <70 (Group 2). We compared tumor pathological characteristics and the results of long-term follow-up in both groups. The frst group included 76 (16.7%), and the second group 379 (83.3%) patients. The mean age of the patients was 73.3±3.01 years (70-85) in Group 1 and 58.3±7.47 years (34-69) in Group 2. The American Society of Anesthesiologists (ASA) score was less than three in all of the patients, and there was no risk for major surgery. Results: No statistically signifcant difference was found between groups with respect to pathological T stage (p=0.567), lymph node involvement (p=0.179), or histological grade (p=0.567). Perioperative mortal- ity rates were 3.9, and 3.4% in groups 1 and 2, respectively (p=0.218). Perioperative complication rates were 14.7, and 17.5% for groups 1, and 2 respectively (p=0.578). Five-year disease-specifc survival (DSS) rates were 57.0, and 51.6% Groups 1, and 2, respectively. The mean DSS periods were 82.05±4.88 and 71.68±8.53 months for Groups 1, and 2, respectively. Five-year overall survival rates were 43.9% for Group 1 and 45.9% for Group 2. The mean overall survival times were 54.02±8.47, and 69.25±4.97 months for Groups 1, and 2, respectively. In Cox regression analysis, tumor stage (p=0.012) and lymph node involvement (p<0.001) were signifcant factors that affected the survival in both groups. None of the patients received neoadjuvant radiotherapy or chemotherapy. Conclusion: We found that oncological outcomes of radical cystectomy performed with the indication of bladder tumor were comparable between young and elderly. We believe that age per se should not constitute a contraindication for radical cystectomy operations.

🔖

Cite This Article

GÖRGEL, S. N., ŞEFK, E., BALCI, U., ÖZER, K., GİRGİN, C., DİNÇEL, Ç. (2014). The feasibility of radical cystectomy in elderly patients. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 40 - Sayı: 1, 9–14. https://ajindex.com/articles/328894

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Hoyert DL, Kochanek MA, Murphy SL. Deaths: Final data for 1997. Nat Vital Stat Rep 1999;47:1-105
  2. Lance RS, Grossman HB. Cystectomy in the elderly. Semin Urol Oncol 2001;19:51-5
  3. Vincent GK, Velkoff VA. The older population in the United States: 2010 to 2050. U.S. Census Bureau 2010
  4. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92. [CrossRef] 5. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer 2002;15:2766-92. [CrossRef] 6. Probability of developing invasive cancers over selected age intervals by sex, US, 2002-2004. American Cancer Society Web site. http://www.cancer.org/downloads/stt/CFF2008Table_pg14. pdf. Accessed April 18, 2009
  5. Stenzl A, Cowan NC, De Santis M, Jakse G, Kuczyk MA, Axel S, et al. The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer 2009;55:815-25
  6. Skinner EC, Lieskovsky G, Skinner DG. Radical cystectomy in the elderly patient. J Urol 1984;131:1065-8
  7. Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW. Radical cystectomy in octogenarians-does morbidity outweigh the potential survival benefits? J Urol 2010;183:2171-7. [CrossRef] 10. Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diag- nosis. Urology 2005;66:4-34. [CrossRef] 11. Murphy WM, Farrow GM, Beckwith B. Renal and bladder tumors. AFIP Fascicle Series. Washington DC: American Registry of Pathology 1994
  8. Kantor AF, Hartge P, Hoover RN, Fraumeni JF Jr. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder. Cancer Res 1988;48:3853-5
  9. El Sabai I. Cancer of the bladder in Egypt. Proc hit Symp Bilharziasis (Cairo) 1996;1:709-23
  10. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, et al. American Cancer Society. CA Cancer J Clin 2004;54:8-29. [CrossRef] 15. Fleshner N, Kondylis E. Demographics and epidemiology of uro- thelial cancer of the urinary bladder. In Droller MI(ed): Urothelial Tumors. Hamilton, Ontario: Decker 2004.p.1-16
  11. Crews DE, Zavotka S. Aging, disability, and frailty: implications for universal design. J Physiol Anthropol 2006;25:113-8. [CrossRef] 17. Raghavan D. Management of advanced bladder cancer in the elderly. Urol Clin No